Polygenic dissection of treatment-resistant depression with proxy phenotypes in the UK Biobank
Journal of Affective Disorders · 2025-07 · 381 · 350-359
DOI: 10.1016/j.jad.2025.04.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Affective Disorders, 2025-07. Verfasst von Ling-Hua Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Health Data Analytics and Statistics, College of Public Health, National Taiwan University, Taiwan. Hauptthemen laut MEDLINE: Depressive Disorder, Treatment-Resistant, Multifactorial Inheritance, Major Depressive Disorder. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: National Science and Technology Council, Executive Yuan Republic of China Ministry of Education.
Themen: Depression
Abstract (Originalsprache)
BACKGROUND: Treatment-resistant depression (TRD) affects one-third of major depressive disorder (MDD) patients. Previous pharmacogenetic studies suggest genetic variation may influence medication response but findings are heterogeneous. We conducted a comprehensive genetic investigation using proxy TRD phenotypes (TRDp) that mirror the treatment options of MDD from UK Biobank primary care records. METHODS: Among 15,125 White British MDD patients, we identified TRDp with medication changes (switching or receiving multiple antidepressants [AD]); augmentation therapy (antipsychotics; mood stabilizers; valproate; lithium); or electroconvulsive therapy (ECT). Hospitalized TRDp patients (HOSP-TRDp) were also identified. We conducted genome-wide association analysis, estimated SNP-heritability (hg2), and assessed the genetic burden for nine psychiatric diseases using polygenic risk scores (PRS). RESULTS: TRDp patients were more often female, unemployed, less educated, and had higher BMI, with hospitalization rates twice as high as non-TRDp. While no credible risk variants emerged, heritability analysis showed significant genetic influence on TRDp (liability hg2 21-24 %), particularly for HOSP-TRDp (28-31 %). TRDp classified by AD changes and augmentation carried an elevated yet varied polygenic burden for MDD, ADHD, BD, and SCZ. Higher BD PRS increased the likelihood of receiving ECT, lithium, and valproate by 1.27-1.80 fold. Patients in the top 10 % PRS relative to the average had a 12-36 % and 24-51 % higher risk of TRDp and HOSP-TRDp, respectively. CONCLUSIONS: Our findings support a significant polygenic basis for TRD, highlighting genetic and phenotypic distinctions from non-TRD. We demonstrate that different TRDp endpoints are enriched with various spectra of psychiatric genetic liability, offering insights into pharmacogenomics and TRD's complex genetic architecture.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Health Data Analytics and Statistics, College of Public Health, National Taiwan University, Taiwan.
- Institute of Health Data Analytics and Statistics, College of Public Health, National Taiwan University, Taiwan; Department of Public Health, College of Public Health, National Taiwan University, Taiwan.
- Center for Neuropsychiatric Research, National Health Research Institutes, Miaoli, Taiwan; Department of Public Health & Medical Humanities, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan;…
- Department of Public Health, College of Public Health, National Taiwan University, Taiwan; Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan; Departm…
- Institute of Health Data Analytics and Statistics, College of Public Health, National Taiwan University, Taiwan; Department of Public Health, College of Public Health, National Taiwan University, Taiwan; Institute of Ep…
Förderung
- National Science and Technology Council
- Executive Yuan Republic of China Ministry of Education
Zitieren
APA
Wang, L. H., Shih, M. Y., Lin, Y. F., Kuo, P. H., & Feng, Y. A. (2025). Polygenic dissection of treatment-resistant depression with proxy phenotypes in the UK Biobank. Journal of Affective Disorders, 381, 350-359. https://doi.org/10.1016/j.jad.2025.04.012
Vancouver
Wang LH, Shih MY, Lin YF, Kuo PH, Feng YA. Polygenic dissection of treatment-resistant depression with proxy phenotypes in the UK Biobank. Journal of Affective Disorders. 2025;381:350-359. doi:10.1016/j.jad.2025.04.012
BibTeX
@article{Wang2025,
author = {Wang, Ling-Hua and Shih, Mu-Yi and Lin, Yen-Feng and Kuo, Po-Hsiu and Feng, Yen-Chen A},
title = {Polygenic dissection of treatment-resistant depression with proxy phenotypes in the UK Biobank},
journal = {Journal of Affective Disorders},
year = {2025},
volume = {381},
pages = {350--359},
doi = {10.1016/j.jad.2025.04.012}
}
EUVIMED